Evidence map›Paper›PMID 41502936›Full record

ArticlebioRxiv : the preprint server for biology2026

Co-evolved Partners of Immunity: A Trait-Based Map of Human Keystone Organisms.

Amir Asiaee, Natalie Mallal, Elizabeth Phillips, Simon Mallal

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amir AsiaeeDepartment of Biostatistics, Vanderbilt University Medical Center, TN, USA.ORCID 0000-0002-5317-9820
Natalie MallalCollege of Arts and Science, Vanderbilt University, TN, USA.ORCID 0009-0001-5729-4260
Elizabeth PhillipsDepartment of Medicine, Vanderbilt University Medical Center, TN, USA.ORCID 0000-0002-7623-3383
Simon MallalDepartment of Medicine, Vanderbilt University Medical Center, TN, USA.ORCID 0000-0002-7036-1309

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Ben Ho Park · 1995 to 2026
$172.8M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI John Koethe · 2015 to 2026
$27.5M
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal NecrolysisU01AI154659 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH · 2020 to 2025
$15.5M
Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH, RODEN, DAN M · 2015 to 2019
$13.0M
Pharmacogenomics of HIV TherapyR01AI077505 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HAAS, DAVID W · 2008 to 2025
$12.3M
Vanderbilt-coordinated human Virome Collaborative Center (V2C2)U54AG089326 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Bradley A. Malin · 2025 to 2026
$12.0M
The intersection of immunity and cardiovascular diseasesP01HL174442 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David G Harrison · 2025 to 2026
$8.8M
Mechanisms of Immune Activation in HypertensionR35HL140016 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRISON, DAVID G · 2018 to 2024
$5.3M
Immunogenetic predictors of active and incipient TB in HIV-negative and -positive close TB contactsR01AI147765 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ANDRADE, BRUNO DE BEZERRIL, HAWN, THOMAS R · 2019 to 2023
$4.3M
HIV-1 adaptation to HLA-restricted immune responsesR01AI060460 · NIAID · MURDOCH UNIVERSITY · PI MALLAL, SIMON ALEXANDER · 2004 to 2008
$1.3M
Causal Effect Estimation of Regulatory MoleculesR00HG011367 · NHGRI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ASIAEETAHERI, AMIR · 2021 to 2023
$734k
NCI NIH HHS P30 CA068485NHGRI NIH HHS R00 HG011367NHLBI NIH HHS P01 HL174442NHLBI NIH HHS R35 HL140016NIAID NIH HHS P30 AI110527NIAID NIH HHS R01 AI060460NIAID NIH HHS R01 AI077505NIAID NIH HHS R01 AI147765NIAID NIH HHS U01 AI154659NIA NIH HHS U54 AG089326NIGMS NIH HHS P50 GM115305
6 · The paper itself

Abstract

Persistent human-adapted microbes can act as immunological "keystones," organizing host defense across tissues and shaping vulnerability under immune perturbation. More generally, tissue immunity is calibrated by persistent niche-resident organisms that tune compartment-specific thresholds of cytotoxicity and peripheral tolerance; keystone organisms represent the apex subset with multi-niche scope. Here we operationalize keystone organisms as pathogens whose containment requires coordinated engagement of multiple immune arms and whose residence is structured across anatomical niches. Using 18 curated immunological and evolutionary traits across 43 organisms, unsupervised analyses resolved four reproducible archetypes and identified a compact keystone set dominated by persistent herpesviruses and

Indexed as

autoimmunitycoevolutiondiagnostic breadthdrug hypersensitivityimmunodominancekeystone organismsmolecular mimicryRNA virus decoytissue-resident memoryvaccine design

Identifiers

PMID41502936
PMCPMC12773006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.